Table 1. Comparison of demographic and clinical parameters of children who received renal replacement therapy.
| Variables | HD (n=14) | CRRT (n=16) | PD (n=7) | p-value | |
|---|---|---|---|---|---|
| Age at admission (month) | 132 (3–170) | 13 (3–172) | 5 (3–9)# | 0.049 | |
| Sex (female n/%, male n/%) | 6 (42.8%), 8 (57.2%) | 6 (37.5%), 10 (62.5%) | 3 (42.8%), 4 (57.2%) | 0.76 | |
| Weight at admission (kg) | 20 (3–65) | 10 (4–63) | 5.5 (3–7) | 0.07 | |
| Systolic blood pressure at admission (mmHg) | 109.2±8.3# | 69.6±6.1 | 82.7±8.7 | <0.001 | |
| Hearth rate | 133.6±28.6 | 137.7±22.8 | 144.2±21.5 | 0.09 | |
| Primary diagnosis | |||||
| Sepsis | 1 (7.1%) | 11 (68.8%) | 3 (42.8%) | 0.06 | |
| ATN | 7 (50%) | 4 (25%) | 1 (14.2%) | ||
| HUS | 3 (21.4%) | – | 1 (14.2%) | ||
| Metabolic disease | 1 (7.1%) | – | 2 (28.4%) | ||
| Intoxication | 2 (14.2%) | – | – | ||
| Bone marrow transplantation | – | 1 (6.2%) | – | ||
| Comorbidity | |||||
| Respiratory disorders | – | 2 | – | 0.32 | |
| Neurological disorders | 1 | 1 | – | ||
| Renal disorders | 1 | – | – | ||
| Metabolic disorders | 1 | – | 2 | ||
| Hematological-oncological disorders | – | 1 | – | ||
| Duration of ICU (day) | 16 (2–45) | 12 (2–48) | 33 (12–62) | 0.3 | |
| Duration of RRT (day) | 5.8±3.1 | 3.4±1.8 | 6.7±5.9 | 0.52 | |
| Mechanical ventilation support | |||||
| CMV | 5 (35.7%) | 10 (62.5%) | 3 (42.8%) | 0.27 | |
| HFOV | – | 5 (31.3%) | 1 (14.2%) | ||
| NIV | 1 (7.1%) | 1 (6.2%) | – | ||
| PRISM III score | 6 (2–22) | 18 (12–21)# | 9.5 (6–12) | 0.02 | |
| Vasoactive inotropic drug | 2 (22.2%) | 6 (85.7%)# | 2 (50%) | 0.01 | |
| Outcome | |||||
| Survived | 13 (92.8%) | 9 (56.25%) | 6 (85.7%) | 0.02 | |
| Died | 1 (7.2%) | 7 (43.75%)# | 1 (14.3%) | ||
The parameter of the group with (#) sign is significantly higher than those in the other groups.